Coste Catherine — SEC insider filings
SEC reporting owner CIK 1821432. 13 insider filings on record with FilingPulse; latest filed 2026-10-08.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2020-10-27 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 11,290 shares, $56,077 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 9,100 shares @ $5.45 ($49,595) in BIOMERICA INC, filed 2020-10-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMERICA INC (BMRA) | Director | 7 | 2 legs · 11,290 sh · $56,077 | — | 5 |
| BIOLIFE SOLUTIONS INC (BLFS) | Director | 3 | — | — | 3 |
| Renalytix plc (RNLX) | Director | 2 | — | — | 2 |
| MINERVA SURGICAL INC (UTRS) | Director | 1 | — | — | 1 |
Insider filings — Coste Catherine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-08 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Disposition to issuer (D): 13,871 | EDGAR |
| 2026-02-26 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 8,170 | EDGAR |
| 2025-03-20 | 4 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/award (A): 5,701 | EDGAR |
| 2024-12-17 | 4 | BIOMERICA INC (BMRA) | Grant/award (A): 85,000 @ $0.31 | EDGAR |
| 2023-12-14 | 4 | BIOMERICA INC (BMRA) | Grant/award (A): 75,000 (derivative) | EDGAR |
| 2023-12-11 | 4 | BIOMERICA INC (BMRA) | Grant/award (A): 32,000 (derivative) | EDGAR |
| 2023-11-22 | 4 | Renalytix plc (RNLX) | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Renalytix plc (RNLX) | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | BIOMERICA INC (BMRA) | Purchase (P): 2,190 @ $2.96 | EDGAR |
| 2022-06-14 | 4 | MINERVA SURGICAL INC (UTRS) | Grant/award (A): 49,792 @ $2.41 | EDGAR |
| 2021-12-10 | 4 | BIOMERICA INC (BRMA) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2020-12-11 | 4 | BIOMERICA INC (BMRA) | Grant/award (A): 20,000 (derivative) | EDGAR |
| 2020-10-27 | 4 | BIOMERICA INC (BMRA) | Purchase (P): 9,100 @ $5.45 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821432 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs